TGA submissions outline patient impact of medical cannabis ad regulations

Summary

Montu, Australia’s leading plant medicine company, has provided a submission to the Therapeutic Goods Administration (TGA), urging it to amend its advertising guidelines to allow public mention of the term ‘medical cannabis’. Montu understands the TGA is currently working to update its advertising guidelines, which at present do not allow the use of the term ‘cannabis’ when describing medical cannabis products and services.

TGA submissions outline patient impact of medical cannabis ad regulations

Related content

New state-based driving campaign launched, as 99% of patients call for change

TGA submissions outline patient impact of medical cannabis ad regulations

Latest News and Updates

Cannabis Council Australia responds to international meta-analysis on cannabis and psychosis risk

From Roundtable to Reform: a breakfast with CCA

Cannabis Council Australia MyHealthRecord consultation response

Remaking of the Narcotic Drugs Regulation and Narcotic Drugs Regulation

Consultation on pharmacist endorsement for scheduled medicines

Webinar: NSW Driving Laws & Medicinal Cannabis

Cannabis Council Australia welcomes NSW medicinal cannabis driving reforms

Peak body CCA launches Reform Working Group and renews calls for fit-for-purpose regulatory reform of Australia’s medicinal cannabis sector

Cannabis sales plunge in script crackdown – Sydney Morning Herald

Feedback to TGA on draft Standards checklist for medicinal cannabis vaping devices

Cannabis Council Australia proud to support the launch of the National Pain Alliance

Medicinal cannabis scheduling webinar

Medicinal cannabis concerns half-baked, advocates say

Lancet review reinforces the need for stronger medicinal cannabis research

Medicinal Cannabis and the Police – Guidance for Officers and Staff (UK)

Commonwealth funding to strengthen safety, quality, and system integrity for medicinal cannabis products

Submission to the Therapeutic Goods Administration consultation

Position paper: Workplace Drug Testing

Position Paper: Medicinal Cannabis and Driving Laws in Australia

New state-based driving campaign launched, as 99% of patients call for change

Medical cannabis passes 1 million prescriptions despite rampant stigma

Victoria prepares to launch medicinal cannabis driving trial

TGA submissions outline patient impact of medical cannabis ad regulations

Are you part of the medicinal cannabis sector?

Join us as a Supporter

Would you like to learn more about medicinal cannabis?

Join our mailing list

Have a question? Get in touch.

Have a question?
Get in touch.